Ignite Creation Date:
2025-12-24 @ 11:52 AM
Ignite Modification Date:
2026-01-29 @ 2:08 PM
Study NCT ID:
NCT05080361
Status:
UNKNOWN
Last Update Posted:
2021-10-15
First Post:
2021-04-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rechallenge of BRAF +/- MEK Inhibitors Following an Adverse Event in Patients With Cancer
Sponsor:
University Hospital, Caen
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
BRAFREC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None